From news.google.com via
Google News.
()
Off-label use of medicines, though acceptable, is at times still controversial in the medical world. Sometimes the off-label usage is really warranted, at others times it is rarely warranted. But how efficient is the US food and pharmaceutical drug regulator, “the FDA,” in forestalling inappropriate promotion of off-label drug use? The well-known phenomenon called “Off-label use,” refers to the practice of writing prescriptions for drug usage that's beyond the approved scope of a...
Read Full Story
Louisville, KY, March 12, 2007—BioHealthRx, a fast-growing medical jobs careersite announced today that it has signed a partnership agreement with GeneEd, a leading provider of continuing medical education, to offer CME and CE courses for the biotechnology, healthcare and pharmaceutical industries. BioHealthRX will allow medical professionals to choose from a wide range of topics such as Bioinformatics, Human Gene Therapy, Anatomy of the Cardiovascular System, Renal system, Good...
Read Full Story
Manhattan Research, a healthcare marketing services company, has revealed the latest findings from their Cybercitizen(R) Health v7.0. Cybercitizen(R) Health v7.0 is a multi-year, multi-client study and advisory service focused on understanding consumers’ use of information and technology for healthcare.
Included in the findings are three trends pharmaceutical marketers need to consider for 2008.
The three findings that marketers need to consider are:
1. Justifying the Internet as a Channel...
Read Full Story
Know anyone looking for a new career or promotion in the biotechnology, healthcare, or pharmaceutical industries? Tell them about BioHealthRx, www.biohealthrx.com. It is an up and coming site...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Read Full Story
Louisville, KY - BioHealthRx, a fast growing medical job board for the biotechnology, healthcare, and pharmaceutical industries, has announced their partnership with JobTarget, an industry leader in job board development and management, to partner in the JobTarget OneClick Network. By utilizing the OneClick technology, job postings can be done with the simple click of a mouse. The service allows employers, recruiting firms, and HR professionals to post a single job posting...
Read Full Story
In a joint letter from Merck, Pfizer, Eli Lilly, J&J, Novartis and Wyeth, the companies told FASB that that estimating the costs of continuing litigation is ...
More perspectives...
Merck has resolved a warning letter citing GMP violations at its vaccine operations in West Point, Pa., as well as supply constraints for bulk varicella, ...
More perspectives...
From news.google.com via
Google News.
()
"The trial was designed by Merck's marketing division to fulfill a marketing objective," write researchers granted access to internal company memos and ...
More perspectives...
From news.google.com via
Google News.
()
MUMBAI (Reuters) - Dishman Pharmaceuticals & Chemicals Ltd is close to signing contracts with US Merck & Co Inc and AstraZeneca for supplying bulk drugs, ...
More perspectives...
From news.google.com via
Google News.
()
19 (Bloomberg) -- A Merck & Co. study of Vioxx that the company said showed whether the painkiller was easier on the stomach than an older drug was actually ...
More perspectives...
From news.google.com via
Google News.
()
“Merck lobbied every opinion leader, women’s group, medical society, politicians, and went directly to the people – it created a sense of panic that says ...
More perspectives...
From news.google.com via
Google News.
()
According to Pfizer Inc, Merck & Co Inc, Eli Lilly & Co, Johnson & Johnson, Novartis AG and Wyeth, providing such an estimate would be futile, ...
More perspectives...
From news.google.com via
Google News.
()
Pfizer Inc., Merck & Co., Eli Lilly & Co., Johnson & Johnson, Novartis AG and Wyeth want the accounting board to withdraw the proposed rule. ...
More perspectives...
From news.google.com via
Google News.
()
Diakron Pharmaceuticals has secured exclusive rights from Merck to develop, market and distribute an oral anticoagulant drug that Merck tested in Phase I ...
More perspectives...
From news.google.com via
Google News.
()
Eli Lilly'sLLY Elanco division signed an agreement to acquire worldwide rights to Monsanto Company'sMON dairy cow supplement Polisac. Eli Lilly is paying ...
From news.google.com via
Google News.
()
- Eli Lilly announces more changes (topix.com)
